Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation

References

• HickieILloydAAre cytokines associated with neuropsychiatric syndromes in humans?Int J Immunopharmacol19951786776838847162
   PubMed Web of Science ®Google Scholar
• ElenkovIJNeurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-beingNeurochem Int2008521–2405117716784
   PubMed Web of Science ®Google Scholar
• SchlatterJOrtunoFCervera-EnguixSMonocytic parameters in patients with dysthymia versus major depressionJ Affect Disord200478324324715013249
   PubMed Web of Science ®Google Scholar
• MaesMMajor depression and activation of the inflammatory response systemAdv Exp Med Biol1999461254610442165
   PubMed Web of Science ®Google Scholar
• LanquillonSKriegJCBening-Abu-ShachUVedderHCytokine production and treatment response in major depressive disorderNeuropsychopharmacology200022437037910700656
   PubMed Web of Science ®Google Scholar
• GillJVythilingamMPageGGLow cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSDJ Trauma Stress200821653053919107725
   PubMed Web of Science ®Google Scholar
• SutherlandAGAlexanderDAHutchisonJDDisturbance of pro-inflammatory cytokines in post-traumatic psychopathologyCytokine200324521922514596818
   PubMed Web of Science ®Google Scholar
• KonukNTekinIOOzturkUPlasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorderMediators Inflamm20076570417497035
   PubMed Web of Science ®Google Scholar
• CramerAOWaldorpLJvan der MaasHLBorsboomDComorbidity: a network perspectiveBehav Brain Sci2010332–3137150 discussion15019320584369
   PubMed Web of Science ®Google Scholar
• JanssenDGCaniatoRNVersterJCBauneBTA psychoneuroimmunological review on cytokines involved in antidepressant treatment responseHum Psychopharmacol201025320121520373471
   PubMed Web of Science ®Google Scholar
• ReselandSIs current prescription practice of SSRI justifiable?Tidsskr Nor Laegeforen200312318262114714063
   PubMedGoogle Scholar
• De BerardisDContiCMSerroniNThe effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literatureInt J Immunopathol Pharmacol201023241742220646337
   PubMed Web of Science ®Google Scholar
• KuberaMKenisGBosmansEStimulatory effect of antidepressants on the production of IL-6Int Immunopharmacol20044218519214996410
   PubMed Web of Science ®Google Scholar
• KuberaMLinAHKenisGBosmansEvan BockstaeleDMaesMAnti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratioJ Clin Psychopharmacol200121219920611270917
   PubMed Web of Science ®Google Scholar
• VollmarPHaghikiaADermietzelRFaustmannPMVenlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture modelInt J Neuropsychopharmacol200811111111717445357
   PubMed Web of Science ®Google Scholar
• PiletzJEHalarisAIqbalOPro-inflammatory biomakers in depression: treatment with venlafaxineWorld J Biol Psychiatry200811119117270
   PubMed Web of Science ®Google Scholar
• DebonnelGSaint-AndreEHebertCde MontignyCLavoieNBlierPDifferential physiological effects of a low dose and high doses of venlafaxine in major depressionInt J Neuropsychopharmacol2007101516116690006
   PubMed Web of Science ®Google Scholar
• TrivediMHDesaiahDOssannaMJPritchettYLBrannanSKDetkeMJClinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetineInt Clin Psychopharmacol200823316116918408530
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual for Mental Disorders4th edWashingtonAmerican Psychiatric Association1994
   Google Scholar
• VenturaJLibermanRPGreenMFShanerAMintzJTraining and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P)Psychiatry Res19987921631739705054
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry1978133429435728692
   PubMed Web of Science ®Google Scholar
• MaesMScharpeSMeltzerHYRelationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depressionPsychiatry Res199349111277511248
   PubMed Web of Science ®Google Scholar
• BerkMWadeeAAKuschkeRHO’Neill-KerrAAcute phase proteins in major depressionJ Psychosom Res19974355295349394269
   PubMed Web of Science ®Google Scholar
• KagayaAKugayaATakebayashiMPlasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in JapanNeuropsychobiology2001432596211174046
   PubMed Web of Science ®Google Scholar
• LevineJBarakYChengappaKNRapoportARebeyMBarakVCerebrospinal cytokine levels in patients with acute depressionNeuropsychobiology199940417117610559698
   PubMed Web of Science ®Google Scholar
• KuberaMKenisGBosmansEPlasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remissionPol J Pharmacol200052323724111055582
   PubMedGoogle Scholar
• FrommbergerUHBauerJHaselbauerPFraulinARiemannDBergerMInterleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remissionEur Arch Psychiatry Clin Neurosci199724742282339332905
   PubMed Web of Science ®Google Scholar
• KenisGMaesMEffects of antidepressants on the production of cytokinesInt J Neuropsychopharmacol20025440141212466038
   PubMed Web of Science ®Google Scholar
• XiaZDePierreJWNassbergerLTricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cellsImmunopharmacology199634127378880223
   PubMed Web of Science ®Google Scholar
• MaesMSongCLinAHNegative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretionNeuropsychopharmacology199920437037910088138
   PubMed Web of Science ®Google Scholar
• BudziszewskaBBasta-KaimAKuberaMEffect of lipopolysaccharide and antidepressant drugs on glucocorticoid receptor-mediated gene transcriptionPharmacol Rep200557454054416129923
   PubMed Web of Science ®Google Scholar
• WangWDanielssonASvanbergELundholmKLack of effects by tricyclic antidepressant and serotonin inhibitors on anorexia in MCG 101 tumor-bearing mice with eicosanoid-related cachexiaNutrition2003191475312507639
   PubMed Web of Science ®Google Scholar
• ShenYConnorTJNolanYKellyJPLeonardBEDifferential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the ratLife Sci199965171773178610576557
   PubMed Web of Science ®Google Scholar
• HashiokaSKlegerisAMonjiAAntidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxideExp Neurol20072061334217481608
   PubMed Web of Science ®Google Scholar
• ElenkovIJChrousosGPStress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to DiseaseTrends Endocrinol Metab199910935936810511695
   PubMed Web of Science ®Google Scholar